Annual EBIT
-$79.13 M
+$10.02 M+11.24%
December 31, 2023
Summary
- As of February 8, 2025, XLO annual earnings before interest & taxes is -$79.13 million, with the most recent change of +$10.02 million (+11.24%) on December 31, 2023.
- During the last 3 years, XLO annual EBIT has fallen by -$24.57 million (-45.03%).
- XLO annual EBIT is now -315.90% below its all-time high of -$19.03 million, reached on December 31, 2019.
Performance
XLO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$14.80 M
-$129.00 K-0.88%
September 30, 2024
Summary
- As of February 8, 2025, XLO quarterly earnings before interest & taxes is -$14.80 million, with the most recent change of -$129.00 thousand (-0.88%) on September 30, 2024.
- Over the past year, XLO quarterly EBIT has increased by +$3.33 million (+18.35%).
- XLO quarterly EBIT is now -1.23% below its all-time high of -$14.62 million, reached on September 30, 2020.
Performance
XLO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$64.15 M
+$2.56 M+3.83%
September 30, 2024
Summary
- As of February 8, 2025, XLO TTM earnings before interest & taxes is -$64.15 million, with the most recent change of +$2.56 million (+3.83%) on September 30, 2024.
- Over the past year, XLO TTM EBIT has increased by +$14.99 million (+18.94%).
- XLO TTM EBIT is now -338.67% below its all-time high of -$14.62 million, reached on September 30, 2020.
Performance
XLO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
XLO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.2% | +18.4% | +18.9% |
| 3 y3 years | -45.0% | +18.4% | +18.9% |
| 5 y5 years | - | +18.4% | +18.9% |
XLO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.5% | +11.2% | -0.9% | +39.7% | at high | +29.9% |
| 5 y | 5-year | -315.9% | +11.2% | -1.2% | +39.7% | -338.7% | +29.9% |
| alltime | all time | -315.9% | +11.2% | -1.2% | +39.7% | -338.7% | +29.9% |
Xilio Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$14.80 M(+0.9%) | -$64.15 M(-3.8%) |
| Jun 2024 | - | -$14.67 M(-11.3%) | -$66.70 M(-7.5%) |
| Mar 2024 | - | -$16.54 M(-8.8%) | -$72.15 M(-8.8%) |
| Dec 2023 | -$79.13 M(-11.2%) | -$18.13 M(+4.4%) | -$79.13 M(-6.0%) |
| Sep 2023 | - | -$17.36 M(-13.7%) | -$84.17 M(-3.3%) |
| Jun 2023 | - | -$20.12 M(-14.5%) | -$87.02 M(-4.9%) |
| Mar 2023 | - | -$23.53 M(+1.5%) | -$91.45 M(+2.6%) |
| Dec 2022 | -$89.15 M | -$23.17 M(+14.7%) | -$89.15 M(+4.2%) |
| Sep 2022 | - | -$20.21 M(-17.7%) | -$85.54 M(+5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$24.55 M(+15.7%) | -$81.29 M(+1.9%) |
| Mar 2022 | - | -$21.22 M(+8.5%) | -$79.75 M(+6.3%) |
| Dec 2021 | -$75.04 M(+37.5%) | -$19.56 M(+22.5%) | -$75.04 M(-1.4%) |
| Sep 2021 | - | -$15.96 M(-30.6%) | -$76.08 M(+1.8%) |
| Jun 2021 | - | -$23.01 M(+39.3%) | -$74.75 M(+44.5%) |
| Mar 2021 | - | -$16.52 M(-19.8%) | -$51.74 M(+46.9%) |
| Dec 2020 | -$54.56 M(+186.8%) | -$20.59 M(+40.8%) | -$35.22 M(+140.8%) |
| Sep 2020 | - | -$14.62 M | -$14.62 M |
| Dec 2019 | -$19.03 M | - | - |
FAQ
- What is Xilio Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Xilio Therapeutics?
- What is Xilio Therapeutics annual EBIT year-on-year change?
- What is Xilio Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly EBIT year-on-year change?
- What is Xilio Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Xilio Therapeutics?
- What is Xilio Therapeutics TTM EBIT year-on-year change?
What is Xilio Therapeutics annual earnings before interest & taxes?
The current annual EBIT of XLO is -$79.13 M
What is the all time high annual EBIT for Xilio Therapeutics?
Xilio Therapeutics all-time high annual earnings before interest & taxes is -$19.03 M
What is Xilio Therapeutics annual EBIT year-on-year change?
Over the past year, XLO annual earnings before interest & taxes has changed by +$10.02 M (+11.24%)
What is Xilio Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of XLO is -$14.80 M
What is the all time high quarterly EBIT for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly earnings before interest & taxes is -$14.62 M
What is Xilio Therapeutics quarterly EBIT year-on-year change?
Over the past year, XLO quarterly earnings before interest & taxes has changed by +$3.33 M (+18.35%)
What is Xilio Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of XLO is -$64.15 M
What is the all time high TTM EBIT for Xilio Therapeutics?
Xilio Therapeutics all-time high TTM earnings before interest & taxes is -$14.62 M
What is Xilio Therapeutics TTM EBIT year-on-year change?
Over the past year, XLO TTM earnings before interest & taxes has changed by +$14.99 M (+18.94%)